Demographic and Socio-Cultural Determinants of Intended and Unintended Pregnancies Among Women Under Cancer Treatment in Sistan and Baluchestan Province, Iran


avatar Khadijeh Asadisarvestani ORCID 1 , * , avatar Maryam Navaee ORCID 2

Department of Social Sciences, Faculty of Literature and Humanities, University of Sistan and Baluchestan, Zahedan, Iran
Midwifery Department, Pregnancy Health Research Centre, Zahedan University of Medical Sciences, Zahedan, Iran

how to cite: Asadisarvestani K, Navaee M . Demographic and Socio-Cultural Determinants of Intended and Unintended Pregnancies Among Women Under Cancer Treatment in Sistan and Baluchestan Province, Iran. Shiraz E-Med J.22(11):e111304. doi: 10.5812/semj.111304.



One of the main concerns during cancer treatment is the occurrence of pregnancy due to its wide range of complications.


This study aimed to determine some influential factors on pregnancy during cancer treatment among women of reproductive ages that were under cancer treatment.


This cross-sectional study investigated 133 women of reproductive age, who were under cancer treatment, as well as women who had undergone chemotherapy or radiotherapy up to one year ago in Sistan and Baluchestan Province. Data were collected from three medical centers in Zahedan from 2019 to 2020, using a researcher-made questionnaire.


Regarding the pregnancy rate, 23.0% of women had pregnancy during cancer treatment, including unintended (52.0%) and intended (48.0%) pregnancies that 55.0% of these pregnancies led to abortion, and 45.0% to livebirths. The results highlighted that during treatment women with and without pregnancy differed significantly in age (P = 0.001), ethnicity (P = 0.024), husband’s education level (P = 0.014), woman’s occupation (P = 0.021), couple’s agreement on number of children (P = 0.024), and physician consultation about contraceptives (P = 0.048). The main predictors of pregnancy were the woman’s age pregnancy (OR = 0.927, P = 0.011), occupation (OR = 0.358, P = 0.046), and ethnicity (OR = 2.49, P = 0.045).


Considering the complications of pregnancy during cancer treatment, health planners should pay more attention to family planning for women under treatment, particularly in less developed regions.

1. Background

Cancer, as the second leading cause of mortality, is increasing around the world (1), especially in developing countries. It is predicated that the prevalence of cancer will increase from around 56% in 2008 to 60% by 2030 in less developed countries (2). In Iran, cancer, as the second largest group of chronic non-communicable diseases (3) and the third cause of mortality, has shown an increasing trend (3-5). Pregnancy and reproductive health are important issues in cancer survivors and patients undergoing cancer treatment; however, limited attention has been paid to these issues and the social and cultural factors.

Cancer treatment can negatively affect women’s reproductive power (5-8). Obviously, women are under major stress during treatment, and the occurrence of pregnancy can increase the severity of stress (7) and disrupt their treatment and recovery processes. These groups of women are more likely to terminate their pregnancy (9, 10), while some of these women, even those with life-threatening conditions, may refuse treatment due to their fear of harm to the fetus (11). It is documented that radiotherapy and chemotherapy during the first trimester of pregnancy can increase the rate of congenital malformations and spontaneous abortion (9, 12), and some methods of cancer treatment can increase the risk of pregnancy loss, preterm birth, low birth weight, and birth of children with special needs (10-12).

Accordingly, it is recommended that women avoid pregnancy during cancer treatment. Also, women with hormone-sensitive cancers are advised to avoid pregnancy three years after treatment, that is, the period of peak recurrence (5, 13). However, it is observed that unintended pregnancy occurs more frequently among women who have chronic medical conditions (14). On the one hand, women under cancer treatment or cancer survivors may assume that they become infertile during or after treatment (15, 16), and on the other hand, physicians, as care providers, only focus on cancer treatment plans and outcomes (17) and may assume that women of this group are not sexually active due to their disease (15).

As a result, identifying factors influencing pregnancy among cancer patients is of great importance. Although there are many studies on unintended pregnancy and contraceptive use, few studies have examined pregnancy, abortion, and contraceptive use among women with cancer (18, 19). All previous researches, reviewed in the present study, found pregnancies during cancer treatment to be unintended. Here, the question arises as to whether all pregnancy is unintended in all groups of women. To the best of our knowledge, there is no study about pregnancy in women undergoing cancer treatment or cancer survivors in Iran. Therefore, the present study aimed to identify influential factors, particularly demographic and sociocultural factors affecting pregnancy in women of reproductive ages in Zahedan City, Iran who were undergoing chemotherapy or radiotherapy, in addition to women who had undergone their last chemotherapy or radiotherapy up to one year ago.

Zahedan is the capital of Sistan and Baluchestan Province which is the second largest province in Iran, which has a border with Afghanistan and Pakistan and has special socioeconomic, cultural, and political circumstances. Among all provinces of Iran, Sistan and Baluchestan has the lowest rank in human development indices (20), and 25% of women, aged 14 - 44 years, are illiterate (21). The last census in Iran demonstrated that this province has the highest rate of total fertility (3.96%) (22), which indicates the lower prevalence of contraceptive use, compared to other regions of Iran. Also, this province is among provinces of Iran with the highest prevalence of unwanted pregnancy (20.7%) (23).

Although the incidence of cancer is lower in Sistan and Baluchestan, the cancer trends are increasing in this region (24).

2. Objectives

Therefore, the findings of the present study can be useful for physicians and family planning service providers to obtain more information about high-risk groups. Our findings may also be considered by health planners to decrease the rate of pregnancy during cancer treatment and to curb its consequences in Iran, particularly in Sistan and Baluchestan Province.

3. Methods

This cross-sectional study was carried out between September 2019 and August 2020 on 133 women of reproductive age (15 - 49 years) with cancer, who were referred to Khatam Hospital, Imam Ali Hospital, and Dr. Hashemi's office (an oncologist) for chemotherapy or radiotherapy, in addition to women who had undergone treatment at least one year ago in Zahedan. Regards to sample size, it should be explained that due to uncertain number of women under cancer treatment, census method was employed to find the samples. The subjects were selected by purposive sampling. The inclusion criteria were as follows: absence of infertility; absence of cancers associated with the removal of important reproductive organs; lack of menopause; and living with the spouse even periodically. On the other hand, infertility, the presence of cancers associated with the removal of important reproductive organs, reluctance to interview, and lack of favorable conditions to continue the interview were the exclusion criteria.

A researcher-made questionnaire was used for data collection. The content validity of the questionnaire was examined in this study. The questionnaire was revised, based on the feedback and recommendations of five experts in the fields of family planning and cancer. As the main items of this instrument were gathered from previous studies (25, 26), its face validity was confirmed. A pilot study was performed a month before the main part of the research in order to evaluate the reliability of the questionnaire.

The collected data were analyzed in SPSS-18. For categorical variables, Pearson’s chi-square test was used to find differences between women with and without experience of pregnancy, based on the demographic, sociocultural, and accessibility factors. Fisher’s exact test was also run to see whether the number of observations was below five in any of the nominal variables. Finally, we used multinomial logistic regression to discover the main predictors of pregnancy. The odds ratio (OR) was measured at a 95% confidence interval (CI). The maximum likelihood method was used to estimate the coefficients of logistic regression models. All variables with a P-value less than 0.05 were considered statistically significant. Also, the fitness of the proposed models was assessed using different goodness-of-fit indices, including the Hosmer-Lemeshow (H-L) test and goodness-of-fit measures such as Cox-Snell, R2 and Nagelkerke R2.

4. Results

Table 1 presents the participants’ socioeconomic and demographic characteristics. Overall, 46 (34.6%) of women were 40 - 44 years old, and 52 (39.0%) of women were 30 - 39 years old. Also, 66 (46.6%) of respondents had less three years of age difference with their husbands. In terms of ethnicity, 72 (54.1%) and 55 (41.4%) of respondents were Fars and Baluch, respectively. Regarding education level, 41 (30.8%) and 39 (29.3%) of women had secondary and tertiary education, respectively. In addition, 43 (32.3%) and 36 (27.0%) of respondents respectively said that their husband have tertiary and secondary education. The results showed that 102 (77.0%) of women lived in urban areas, and 96 (72%) were housewives. Also, 22 (16.5%) of respondents mentioned that their husbands had another wife or wives. In terms of power structure in the family 75 (56.4%) and 49 (36.8%) of women mentioned that decisions about major issues and health/medical issues in the family were made jointly and only by their husbands, respectively.

Table 1. Demographic Background of the Participants (N = 133)
VariablesNo. (%)
Age group, y
15 - 19 2 (1.5)
20 - 249 (6.8)
25 - 2924 (18.0)
30 - 3426 (19.5)
35 - 3926 (19.5)
40 - 4446 (34.6)
45 - 492 (1.5)
Spousal age difference, y
< 331 (23.3)
3 - 662 (46.6)
7 - 1029 (21.8)
> 1011 (8.3)
Fars72 (54.1)
Baluch55 (41.4)
Others6 (4.5)
Education level
Illiterate16 (12.0)
Elementary school37 (27.8)
Secondary school41 (30.8)
Tertiary school39 (29.3)
Husband’s education
Illiterate19 (14.3)
Elementary school35 (26.3)
Secondary school36 (27.1)
Tertiary school43 (32.3)
Occupational status
Housewife96 (72.2)
Employee37 (27.8)
Yes22 (16.5)
No111 (83.5)
Place of residence
Urban102 (76.7)
Rural31 (23.3)
Decisions about important issues are made by
Respondent5 (3.8)
Husband56 (42.1)
Jointly72 (54.1)
Decisions about health/medical issues are made by
Respondent9 (6.8)
Husband49 (36.8)
Jointly75 (56.4)

Table 2 shows that the desired number of children was 3 - 4 in 58 (43.6%) of respondents, and 58 (43.6%) of women desired more than four children. Also, 47 (35.3%) of couples did not agree on the number of children, and 22 (16.5%) couples did not agree on the contraceptive method. Almost half of women claimed that they were going to become pregnant in the future. In terms of gender preference, 61 (45.9%) of women preferred to have a boy than a girl. The results also showed that 49 (37.0%) of women did not have any knowledge about the emergency contraceptive methods. Regarding the accessibility factors, 130 (97.7%) of women were less than 30 minutes away from both health centers and pharmacies. Also, 61 (46.6%) of women claimed that the physician responsible for their cancer treatment never discussed contraceptives.

Table 2. Distribution of Participants Based on Some Fertility and Contraception Indicators (N = 133)
VariablesNo. (%)
Desired number of children
00 (0)
1 - 217 (12.8)
3 - 458 (43.6)
> 458 (43.6)
Couple’s agreement on the number of children
Yes70 (52.6)
No (husband wants more children)45 (33.8)
No (respondent wants more children)2 (1.5)
Do not know16 (12.0)
Do you want to become pregnant in the future?
Yes66 (49.6)
No67 (50.4)
Couple’s agreement on the contraceptive method
Yes111 (83.5)
No22 (16.5)
Son preference
Yes61 (45.9)
No72 (54.1)
Contraceptive method
Withdrawal31 (23.3)
Condoms43 (32.3)
Pills42 (31.6)
No method15 (11.3)
Other methods2 (1.5)
Knowledge about the emergency method
Yes 84 (63.2)
No49 (36.8)
Distance from health centers, min
< 30 123 (92.5)
30 - 60 10 (7.5)
> 600 (0)
Distance from pharmacies, min
< 30 130 (97.7)
30 - 60 130 (2.3)
Did your doctor discuss contraception?
Yes71 (53.4)
No62 (46.6)

Furthermore, Figure 1 shows that 31 (23.0%) of respondents had the experience of pregnancy during cancer treatment or up to one year after the last chemotherapy or radiotherapy session. In more detail, 15 (48.0%) of pregnancies were unintended, and 16 (51.0%) were intended. In terms of pregnancy outcomes, 17 (55.0%) of women had abortions, and 14 (45.0%) had livebirths.

The Prevalence of Pregnancy among Women and Pregnancy Outcome

4.1. Outcome

Table 3 presents a comparison of women with and without experience of pregnancy regarding the demographic, sociocultural, and accessibility factors. The results showed a significant relationship between age and pregnancy (P = 0.001), and the highest pregnancy rate was reported in women aged 20 - 24 years. Also, there was a significant relationship between pregnancy and ethnicity, and the highest pregnancy rate was seen in Baluch women (P = 0.024). The husband’s education level also had a significant relationship with pregnancy (P = 0.014), with the highest rate of pregnancy among women whose husbands were illiterate.

Table 3. Comparison of Women with and Without Experience of Pregnancy in Terms of Socioeconomic, Cultural, and Accessibility Factors
Yes, No. (%)No, No. (%)
Age group19.620.001
15 - 191 (50.0)1 (50.0)
20 - 246 (66.7)3 (33.3)
25 - 298 (33.3)16 (66.7)
30 - 348 (30.8)18 (69.2)
35 - 391 (3.8)25 (96.2)
40 - 443 (13.0)20 (87.0)
45 - 494 (17.4)19 (82.6)
Spousal age difference, mean0.7570.860
< 38 (25.8)23 (74.2)
3 - 613 (21.0)49 (79.0)
7 - 108 (27.6)21 (72.4)
> 102 (18.2)9 (81.8)
Fars12 (16.7)60 (83.3)
Baluch15 (27.3)40 (72.7)
Non-Fars2 (17.7)4 (81.3)
Respondent’s education level3.670.299
Illiterate3 (18.8)13 (81.0)
Primary school5 (13.5)32 (86.5)
Secondary school11 (26.8)30 (73.2)
Tertiary school12 (30.8)27 (69.2)
Husband’s education level9.410.014
Illiterate15 (34.9)28 (65.1)
Primary school9 (25.7)26 (74.3)
Secondary school7 (19.4)29 (80.6)
Tertiary school0.0100.0
Employment status6.050.021
Employee14 (17.723 (82.3)
Housewife17 (37.8)79 (62.2)
Yes7 (31.8)15 (68.2)
No24 (21.6)87 (78.4)
Place of residence2.440.089
Urban27 (26.5)75 (73.5)
Rural4 (12.9)27 (87.1)
Desired number of children2.360.307
1 - 24 (23.5)13 (76.5)
3 - 410 (17.2)48 (82.8)
> 417 (29.3)41 (70.7)
Couple’s agreement on the number of children4.770.024
Yes11 (15.7)59 (84.3)
No20 (31.7)43 (68.3)
Couple’s agreement on the contraceptive method1.200.188
Yes27 (24.3)84 (75.7)
No4 (18.2)18 (81.8)
Son preference1.310.174
Yes17 (27.9)44 (72.1)
No14 (19.4)58 (80.6)
Did your doctor discuss contraception?
Yes12 (16.9)59 (83.1)3.50.048
No19 (30.6)43 (69.4)
Distance from health centers, min
< 30 31 (25.2)92 (74.8)3.280.063
30 - 600 (0.0)10 (100.0)
> 60000.00
Distance from pharmacies, min0.1730.552
< 30 30 (23.1)100 (76.9)
30 - 60 1 (33.3)2 (66.7)
> 600000

In terms of occupation, the results showed that pregnancy had a significant relationship with occupation (P = 0.021), and the highest rate of pregnancy was reported in housewives. Couple’s agreement on the contraceptive method was also another variable with a significant relationship with pregnancy (P = 0.024). The highest rate of pregnancy was found in women who did not agree with their husband about the contraceptive method. Moreover, there was a significant relationship between pregnancy and physician consultation about the contraceptive method (P = 0.048), and the highest rate of pregnancy was obsereved in women, who claimed that their physician did not discuss the contraceptive use.

Table 4 presents the prediction of pregnancy, based on the logistic regression analysis. Also, we calculated the fitness of proposed model using the Hosmer-Lemeshow (H-L) test and goodness-of-fit measures, including Cox, Snell R2, and Nagelkerke R2. The results showed that the main predictors of pregnancy were woman’s age (OR = 0.927, 95% CI: 0.446 - 0.899, P = 0.011), ethnicity (OR = 2.49, 95% CI: 1.02 - 7.719, P = 0.045), and occupational status (OR = 0.358, 95% CI: 0.118 - 0.979, P = 0.46).

Table 4. Prediction of Pregnancy During the Treatment Period
VariableBP-ValueOR95% CI
Woman’s age-0.4570.0110.9270.446 - 0.899
Husband’s education level 0.0890.2051.060.952 - 1.255
Physician consultation with the patient about contraception0.5061.690.533 - 3.580
Couple’s agreement on the number of children0.0560.669975 - 7.033
Ethnicity0.0452.491.02 - 7.719
Occupation0.0460.3580.118 - 0.979
Constant value-1.8640.3441.96-

5. Discussion

The results of the present study showed that 23.0% of women had a pregnancy or pregnancies during chemotherapy or radiotherapy and up to one year after the last session of treatment. In terms of the pregnancy outcomes, 55.0% of pregnancies ended in abortion, and about 45% were live birth. However, Shabazin et al. (27) believed that the actual prevalence of unwanted pregnancy in Iran may be higher than the reported rates, because in the Iranian society, some women tend to hide their unwanted pregnancy from others, which makes it difficult to collect accurate information.

Moreover, the rate of pregnancy in the current study was considerably higher than previous studies. A study by Mody et al. (28) in the US showed that 71% of women did not report pregnancy during their primary cancer treatment, while they were sexually active. Another study based on data from the Basel Breast Cancer Database showed that the rate of unintended pregnancy was only 3.5% (8). Moreover, a study by Kopeika et al. (29) on young female breast cancer survivors (with the median time of six years from the time of diagnosis) in the UK found unintended pregnancies in only 7.0% of women, 58% of which were terminated, and around 2.0% were live births.

In terms of the contraceptive use, although nearly 90.0% of women reported using a contraceptive method, only 67.0% used safe methods (condoms and pills), and 23.0% used the withdrawal method, which is not a safe method; also, about 11.0% of women did not use any methods. The withdrawal method, if used carefully, can be as effective as most non-hormonal barrier methods. Only 4% of women using this method are expected to experience an unintended pregnancy within the first year of use; however, due to the high user error, the rate of unintended pregnancy among users is 27% in the first year (30). Moreover, the withdrawal method, as shown by Bommaraju (31), is not effective, because it is prone to user error and does not allow for female reproductive control. Therefore, it can be said that a considerable percentage of women are at risk of unintended pregnancy.

Moreover, a significant proportion of women (37%) were not familiar with emergency contraception. Similarly, Mody et al. (28) in the US reported that 90% of women with cancer used a form of contraceptive in, and the most common method was condom (52%). However, study by Guth (8) also reported that 58% of women with breast cancer used ineffective contraceptive method.

Regarding the determinants of pregnancy among women, the results showed a significant relationship between age and the incidence of pregnancy, and the highest pregnancy rate was reported in women aged 15 - 24 years. It is clear that younger women have not reached their ideal number of children, compared to older women; therefore, the rate of precedency is higher among younger women, which is consistent with another study in Sistan and Baluchestan (32). The current findings also revealed that occupational status is one of the predictors of pregnancy. In other words, the proportion of housewives who became pregnant during treatment was significantly higher than employed women. This may be due to the fact that the desired number of children is lower in employed women; their authority in the family is higher; and they have more exposure to information about contraceptives and complications of pregnancy during treatment (26, 32).

Ethnicity is a cultural variable, which has a significant relationship with fertility. In this study, most pregnancies were reported in Baluch women. This finding is consistent with the study in Sistan and Baluchestan, which found a significant relationship between ethnicity and fertility behavior (32). On the other hand, Asadisarvestani (32) found no significant relationship between ethnicity and fertility behavior in Shiraz County. It was concluded that other social, economic, and cultural factors can undermine the role of ethnicity (26). It seems that the higher fertility rate in Baluch women versus Persian women is due to the impact of variables, such as higher childbearing value, less education, and lower employment rates, affecting fertility behavior and ideals in a certain way.

Physician consultation was one of the predictors of pregnancy. A significantly lower rate of pregnancy was found in women who received advice from their physician about contraception. Moreover, the results showed that half of the respondents claimed that their doctor did not discuss contraception. It is believed that contraceptive counseling by physicians made the patients more likely to use contraception, compared to patients who received no counseling (18). Previous studies have also revealed that 10% - 65% of reproductive-age survivors received contraceptive counseling after their cancer diagnosis (16, 18, 19). Some women might have forgotten the received advice about contraception but it should be accepted that a set of complex variables can affect the quality of counseling. More explanation, the limited number of medical centers and specialists in Zahedan has led to overcrowding; therefore, doctors may pay less attention to consultation about reproductive health issues.

Cultural factors also play an important role. Contraception conversations may be unlikely in clinic rooms, as providers focus on cancer treatment plans and outcomes, and patients may be uncomfortable initiating questions or may be unaware of the need to discuss their concerns with the doctors. Physicians may not clearly explain the issue to patients due to cultural restrictions. The discomfort surrounding contraception is exacerbated if family members are present and the provider is of the opposite gender (18, 33, 34). In addition, since a considerable number of women have low levels of education, they may not accurately understand their physician’s advice regarding pregnancy and contraception.

A study by Crafton (35) showed that only 57% of gynecologic oncologists believed that their patients understood the possibility of unplanned pregnancy during treatment. Research to date suggests that cancer survivors do not receive adequate counseling about safe and effective contraceptives during or after cancer treatment (16, 31, 36). Oncologists should advise patients on the contraceptive methods and the risk of pregnancy before starting treatment until they have achieved good health. The contraceptive efficacy and the adverse effects of each method should be discussed in relation to cancer diagnosis and treatment, as some drug interactions may lower the contraceptive efficacy (36, 37). It is suggested that oncologists refer patients of reproductive age to gynecologists to ensure proper contraceptive counseling (8, 16).

While 90% of women in the present study were close to the health centers (< 30 minutes), the findings showed that a considerable percentage of women purchased contraceptives from pharmacies, while pharmacies, in most cases, did not provide enough information about the contraceptives; this could affect their knowledge of contraceptives, and consequently, lead to a higher rate of failure. Therefore, family planning service providers and physicians need to pay more attention to the delivery of adequate and accurate information about contraceptives to improve the rate of contraceptive use and reduce pregnancy in this group of women, particularly with attention to this fact that the desired number of children was above two in 86.0% of participants in this study, and nearly 50% of them planned on becoming pregnant in the future. The findings of a study by Kopeika et al. (29) in the UK also found that 41% of young breast cancer survivors showed tendency to have children. Similarly, a study by in Beirut, Lebanon, revealed that 30.76% of women wanted more children at the time of diagnosis (38).

It should be noted that contraceptive counseling is not only necessary for women, but is also essential for their husbands, as they play an important role in their partners’ reproductive choices and behaviors. This issue is especially important, as the present findings revealed that important decisions in the family are made by men and that their education level is one of the main predictors of pregnancy during treatment; nevertheless, the education level of 40.0% of men was low in this study, and a considerable number of them desired more children that their wives. In other words, 34% of husbands did not agree with their wives about the number of children, and 17% disagreed about contraception; couple’s agreement on the number of children was one of the main predictors of pregnancy.

Major efforts are needed to increase the spouses’ awareness of the risk of pregnancy during cancer treatment and the importance of contraception (32, 39), because if couples agree on the number of desired children, their agreement about other issues, such as the interval between childbirth and contraceptive use, is greater. These findings are consistent with the results of other studies, which found that men played an important role in women’s ability to make fertility-related decisions (32, 39-43).

In sum, contrary to the common belief that women with cancer are less likely to become pregnant, physicians and family planners should pay more attention to fertility preferences to provide the necessary information for their patients. According to Maslow et al., counseling recommendations for contraceptive use during treatment, besides addressing abstinence and safer sex practices, enable patients to feel more confident in their relationships, help them better express their sexual desires and preferences, and promote their awareness about the risks of unprotected sex (43).

Furthermore, considering the important role of demographic, cultural, and social variables in the incidence of pregnancy during treatment, physicians must pay more attention to the role of these factors to reduce the pregnancy rate and its consequences. Also, due to the widespread presence of health centers in different areas, it can be effective to refer patients along with their spouses to these centers to receive the services and information needed in the field of family planning. Since few studies have been conducted on reproductive health and family planning among women with cancer, it is recommended to conduct similar studies in other regions, especially in areas where the fertility and unintended pregnancy rates are higher.

5.1. Strengths and Limitations

The main strength of this study was its attention to socio-economic factors in addition to the role of accessibilities and structural factors. Furthermore, to the best of our knowledge, this study is the first study on this topic in Iran.

In terms of limitations, the main limitation of this study was its method. More explanation, the method of this study was quantitative, while the mixed method study can bring more depth knowledge. Moreover, the population of this study was limited to Sistan and Baluchestan Province.

5.3. Conclusions

Despite many advances in family planning in Iran, similar to many countries, the rate of unintended pregnancy is high in Iran, especially in areas with a lower socioeconomic status. Women with cancer are a vulnerable group in the community. Contrary to our expectations, not all pregnancies that occurred during the treatment period were unintended, which indicates the shortcomings of family planning programs, such as inadequate attention to vulnerable groups for family planning services and lack of proper communication between medical centers, family planning centers, and couples. Therefore, reducing the rate of pregnancy and its complications among women with cancer depends on multiple factors, such as improving the educational programs and enhancing the relationship between medical centers, family planning centers, and couples. However, this goal cannot be achieved without scientific and accurate knowledge of demographic, social, and cultural characteristics and other influential factors.



  • 1.

    Torre LA, Siegel RL, Ward EM, Jemal A. Global Cancer Incidence and Mortality Rates and Trends--An Update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16-27. doi: 10.1158/1055-9965.EPI-15-0578. [PubMed: 26667886].

  • 2.

    Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108. doi: 10.3322/caac.21262. [PubMed: 25651787].

  • 3.

    Dolatkhah R, Somi MH, Kermani IA, Ghojazadeh M, Jafarabadi MA, Farassati F, et al. Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis. BMC Public Health. 2015;15:997. doi: 10.1186/s12889-015-2342-9. [PubMed: 26423906]. [PubMed Central: PMC4589975].

  • 4.

    Niroomand Moradi Nejad N, Hamayeli Mehrabani H, Sarneyzadeh M, Pormehr Yabandeh A, Hamedy S. A study of cancer prevalence in hormozagan province during 2011. Asian J Med Pharm Res. 2014.

  • 5.

    Danaei M, Haghdoost A, Momeni M. An epidemiological review of common cancers in Iran; a review article. Iran J Blood Cancer. 2019;11(3):77-84.

  • 6.

    Mitwally MF. Fertility preservation and minimizing reproductive damage in cancer survivors. Expert Rev Anticancer Ther. 2007;7(7):989-1001. doi: 10.1586/14737140.7.7.989. [PubMed: 17627459].

  • 7.

    McLaren JF, Bates GW. Fertility preservation in women of reproductive age with cancer. Am J Obstet Gynecol. 2012;207(6):455-62. doi: 10.1016/j.ajog.2012.08.013. [PubMed: 22959764].

  • 8.

    Guth U, Huang DJ, Bitzer J, Moffat R. Unintended pregnancy during the first year after breast cancer diagnosis. Eur J Contracept Reprod Health Care. 2016;21(4):290-4. doi: 10.1080/13625187.2016.1180678. [PubMed: 27227578].

  • 9.

    Hodgson DC, Pintilie M, Gitterman L, Dewitt B, Buckley CA, Ahmed S, et al. Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy. Hematol Oncol. 2007;25(1):11-5. doi: 10.1002/hon.802. [PubMed: 17036376].

  • 10.

    Partridge AH, Gelber S, Peppercorn J, Ginsburg E, Sampson E, Rosenberg R, et al. Fertility and menopausal outcomes in young breast cancer survivors. Clin Breast Cancer. 2008;8(1):65-9. doi: 10.3816/CBC.2008.n.004. [PubMed: 18501060].

  • 11.

    Green DM, Whitton JA, Stovall M, Mertens AC, Donaldson SS, Ruymann FB, et al. Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol. 2002;187(4):1070-80. doi: 10.1067/mob.2002.126643. [PubMed: 12389007].

  • 12.

    Fridgen O, Sehovic I, Bowman ML, Reed D, Tamargo C, Vadaparampil S, et al. Contraception: the Need for Expansion of Counsel in Adolescent and Young Adult (AYA) Cancer Care. J Cancer Educ. 2017;32(4):924-32. doi: 10.1007/s13187-016-1003-8. [PubMed: 26880356].

  • 13.

    Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Me. 1998;338(16):1128-37.

  • 14.

    D'Ambrosio V, Vena F, Di Mascio D, Faralli I, Musacchio L, Boccherini C, et al. Obstetrical outcomes in women with history of breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2019;178(3):485-92. doi: 10.1007/s10549-019-05408-4. [PubMed: 31451975].

  • 15.

    St James PJ, Younger MD, Hamilton BD, Waisbren SE. Unplanned pregnancies in young women with diabetes. An analysis of psychosocial factors. Diabetes Care. 1993;16(12):1572-8. doi: 10.2337/diacare.16.12.1572. [PubMed: 8299452].

  • 16.

    Murphy D, Klosky JL, Termuhlen A, Sawczyn KK, Quinn GP. The need for reproductive and sexual health discussions with adolescent and young adult cancer patients. Contraception. 2013;88(2):215-20. doi: 10.1016/j.contraception.2012.08.041. [PubMed: 23040131].

  • 17.

    Dominick SA, McLean MR, Whitcomb BW, Gorman JR, Mersereau JE, Bouknight JM, et al. Contraceptive Practices Among Female Cancer Survivors of Reproductive Age. Obstet Gynecol. 2015;126(3):498-507. doi: 10.1097/AOG.0000000000000963. [PubMed: 26181090]. [PubMed Central: PMC4545298].

  • 18.

    Mitwally MF. Management of reproductive needs in cancer patients: clinical perspectives. Expert Rev Anticancer Ther. 2008;8(10):1589-95. doi: 10.1586/14737140.8.10.1589. [PubMed: 18925851].

  • 19.

    Britton L. Unintended Pregnancy: A Systematic Review of Contraception Use and Counseling in Women With Cancer. Clin J Oncol Nurs. 2017;21(2):189-96. doi: 10.1188/17.CJON.189-196. [PubMed: 28315546]. [PubMed Central: PMC5878924].

  • 20.

    Biranvandzadeh M, Heshmati Jadid M, Sorkhkamal K. Assessment of development level of Sistan and Baluchistan province compared to other Iran’s provinces. Int J Arch Urban Develop. 2015;5(1):69-76.

  • 21.

    Moudi Z, Ghazi Tabatabaie M, Mahdi Tabatabaei S, Vedadhir A. Safe Delivery Posts: an intervention to provide equitable childbirth care services to vulnerable groups in Zahedan, Iran. Midwifery. 2014;30(10):1073-81. doi: 10.1016/j.midw.2013.06.011. [PubMed: 23866686].

  • 22.

    Iran Statistical Center. Census of population and housing of Iran, 1980. Tehran: Iran Statistical Center; 2017.

  • 23.

    Sayehmiri K, Ebtekar F, Zarei M, Gheshlagh RG. Prevalence of unwanted pregnancy among Iranian women: an updated meta-analysis. BMC Pregnancy Childbirth. 2019;19(1):491. doi: 10.1186/s12884-019-2640-9. [PubMed: 31829158]. [PubMed Central: PMC6907188].

  • 24.

    Rafiemanesh H, Mehtarpoor M, Mohammadian-Hafshejani A, Salehiniya H, Enayatrad M, Khazaei S. Cancer epidemiology and trends in Sistan and Baluchestan province, Iran. Med J Islam Repub Iran. 2015;29:254. [PubMed: 26793645]. [PubMed Central: PMC4715419].

  • 25.

    Rahman H, Khalda E, Kar S, Kharka L, Bhutia GP. Knowledge of, attitudes toward, and barriers to the practice of emergency contraception among women in Sikkim, India. Int J Gynaecol Obstet. 2013;122(2):99-103. doi: 10.1016/j.ijgo.2013.03.016. [PubMed: 23747150].

  • 26.

    Asadisarvestani K. Determinants of fertility behavior and contraceptive usage among married women in the productive age: A case study of Shiraz County, IRAN. Malaysia: University Sains Malaysia; 2016.

  • 27.

    Shahbazin S, Gholamy A. Prevalence Unintended Pregnancy and its Related Factors Among Currently Pregnant Women in Kangavar City (West Iran). J Commun Health Res. 2015;4(1):19-28.

  • 28.

    Mody SK, Gorman JR, Oakley LP, Layton T, Parker BA, Panelli D. Contraceptive utilization and counseling among breast cancer survivors. J Cancer Surviv. 2019;13(3):438-46. doi: 10.1007/s11764-019-00765-x. [PubMed: 31065953]. [PubMed Central: PMC6561485].

  • 29.

    Kopeika J, Bhaduri M, Kugadas A, Reddy N, Shewbridge A, Mukherji D, et al. Planned and unplanned pregnancies in breast cancer survivors. Breast. 2019;46:75-80. doi: 10.1016/j.breast.2019.05.004. [PubMed: 31100574].

  • 30.

    Kowal D. Coitus interruptus (withdrawal). Contraceptive technology. 18th ed. New York: Ardent Media Inc; 2004. p. 311-5.

  • 31.

    Bommaraju A. Determinants of contraceptive choice: factors affecting contraceptive nonuse among urban women utilizing title X services. University of Cincinnati; 2013.

  • 32.

    Asadisarvestani K, Hasanifar A, Bagheri R. Some Determinants of Contraceptive Use Among Women of Reproductive Age Who Have Children with Thalassemia Major in Sistan and Baluchestan Province, Iran. Women’s Health Bul. 2019;6(2):1-7.

  • 33.

    Grady CD, Dehlendorf C, Cohen ED, Schwarz EB, Borrero S. Racial and ethnic differences in contraceptive use among women who desire no future children, 2006-2010 National Survey of Family Growth. Contraception. 2015;92(1):62-70. doi: 10.1016/j.contraception.2015.03.017. [PubMed: 25863228]. [PubMed Central: PMC4468010].

  • 34.

    Patterson P, McDonald FE, Zebrack B, Medlow S. Emerging issues among adolescent and young adult cancer survivors. Semin Oncol Nurs. 2015;31(1):53-9. doi: 10.1016/j.soncn.2014.11.006. [PubMed: 25636395].

  • 35.

    Crafton SM, Lynch CD, Cohn DE, Eisenhauer EL. Reproductive counseling, contraception, and unplanned pregnancy in fertile women treated by gynecologic oncologists. Gynecol Oncol Rep. 2017;19:22-6. doi: 10.1016/j.gore.2016.11.006. [PubMed: 28018956]. [PubMed Central: PMC5173313].

  • 36.

    Koren G. Fetal risks of maternal pharmacotherapy: identifying signals. Handb Exp Pharmacol. 2011;205:285-94. doi: 10.1007/978-3-642-20195-0_14. [PubMed: 21882117].

  • 37.

    Greydanus DE, Pratt HD, Patel DR. Concepts of contraception for adolescent and young adult women with chronic illness and disability. Dis Mon. 2012;58(5):258-320. doi: 10.1016/j.disamonth.2012.02.001. [PubMed: 22510362].

  • 38.

    Assi HI, Kakati RT, Attieh RM, Khoury J, Sukhon F, Berro J, et al. Fertility in Breast Cancer Survivors in the Middle East: A Retrospective Study. Breast. 2020;52:58-63. doi: 10.1016/j.breast.2020.04.010. [PubMed: 32388348]. [PubMed Central: PMC7377329].

  • 39.

    Bankole A, Audam S. Fertility preferences and contraceptive use among couples in sub-Saharan Africa. African Population Studies. 2011;25(2).

  • 40.

    Esber A, Foraker RE, Hemed M, Norris A. Partner approval and intention to use contraception among Zanzibari women presenting for post-abortion care. Contraception. 2014;90(1):23-8. doi: 10.1016/j.contraception.2014.03.006. [PubMed: 24809805].

  • 41.

    Morse JE, Rowen TS, Steinauer J, Byamugisha J, Kakaire O. A qualitative assessment of Ugandan women's perceptions and knowledge of contraception. Int J Gynaecol Obstet. 2014;124(1):30-3. doi: 10.1016/j.ijgo.2013.07.014. [PubMed: 24156991].

  • 42.

    Kohan S, Simbar M, Taleghani F. Empowerment in family planning as viewed by Iranian women: a qualitative study. J Biosoc Sci. 2012;44(2):209-19. doi: 10.1017/S0021932011000563. [PubMed: 22047779].

  • 43.

    Maslow BS, Morse CB, Schanne A, Loren A, Domchek SM, Gracia CR. Contraceptive use and the role of contraceptive counseling in reproductive-aged women with cancer. Contraception. 2014;90(1):79-85. doi: 10.1016/j.contraception.2014.03.002. [PubMed: 24792148].

Copyright © 2021, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.